<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01701193</url>
  </required_header>
  <id_info>
    <org_study_id>ADE001-2011</org_study_id>
    <nct_id>NCT01701193</nct_id>
  </id_info>
  <brief_title>A Phase I Study For the Reduction of Scar Tissue in Adult Females Undergoing Surgery for an Ectopic Pregnancy</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo Controlled Phase I Study of an Amino Acid For the Reduction of Peritoneal Adhesions in Adult Females Undergoing a Laparoscopic Salpingostomy for the Removal of an Ectopic Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AdeTherapeutics Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Saskatchewan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AdeTherapeutics Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an amino acid is an effective treatment to
      prevent abdominal/pelvic scar tissue.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adhesion Reduction</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events in patients from dose administration to 8-week follow up</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Pelvic Adhesions</condition>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1g/kg of body weight, 1 time intra-abdominal administration at time of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amino Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1g/kg of body weight, 1 time intra-abdominal administration at time of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amino Acid</intervention_name>
    <description>Dipeptide</description>
    <arm_group_label>Amino Acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Placebo Comparator</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects are female

          -  Subjects are 18 years of age or older at the time of consent

          -  Subjects have a BMI between 17 and 35

          -  Subjects or subject's legal representative must have signed informed consent form

          -  Subjects have a preoperative diagnosis of an ectopic pregnancy with ultrasonographic
             confirmation of absence of an intrauterine ectopic pregnancy

        Exclusion Criteria:

          -  Subjects whose BMI is outside the range of 17 - 35

          -  Subjects participating in another clinical trial with a drug or a device

          -  Subjects who have participated in a clinical trial with a drug or device within 30
             days prior to this study

          -  Subjects with suspected or diagnosed co-existing intrauterine pregnancy

          -  Subjects with suspected intraabdominal infection

          -  Subjects who are immunocompromised

          -  Subjects diagnosed with cancer

          -  Subjects treated with hemostatic agents (e.g. fibrin sealant, collagen, oxidized
             cellulose)

          -  Subjects treated with adhesion prevention agents other than the Anti-Adhesion Product
             (APP) (e.g. Intergel® Adhesion Prevention Solution, Seprafilm® Membrane)

          -  Subjects taking anti-epileptic medications

          -  Subjects who have been treated with Methotrexate or other chemotherapeutic agents
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donna Chizen, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique C Singh, RN</last_name>
    <phone>(306) 292-7756</phone>
    <email>dominique.singh@usask.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saskatoon Health Region</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique C Singh, RN</last_name>
      <phone>(306) 292-7756</phone>
      <email>dominique.singh@usask.ca</email>
    </contact>
    <investigator>
      <last_name>Donna Chizen, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2012</study_first_submitted>
  <study_first_submitted_qc>October 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2012</study_first_posted>
  <last_update_submitted>October 3, 2012</last_update_submitted>
  <last_update_submitted_qc>October 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
    <mesh_term>Pregnancy, Ectopic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

